Catalyst
Slingshot members are tracking this event:
GlaxoSmithKline (GSK) and Innovia (INVA) Report Top-line from a Non-Inferiority Study of Asthma Patients Switching from Seretide Accuhaler to Relvar Ellipta
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 23, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Top-line, Non-inferiority Study, Asthma Patients, Seretide Accuhaler, Relvar, Ellipta
